Device and Drug Alerts

FDA Requires Warnings about Increased Risk of Serious Heart-Related Events, Cancer, Blood Clots, and Death for JAK Inhibitors that treat Certain Chronic Inflammatory Conditions
FDA: Janus Kinase (JAK) inhibitors: Drug Safety Communication - FDA Requires Warnings about Increased Risk of Serious Heart-related Events, Cancer, Blood Clots, and Death
FDA: Cardinal Health Recalls Argyle UVC Insertion Tray Due to Missing Instructions for Use for the Safety Scalpel N11
FDA: Boston Scientific Recalls INGENIO Family of Pacemakers and CRT-Ps Due to Risk of Incorrect Transition to Safety Mode
Statins: Drug Safety Communication - FDA Requests Removal of Strongest Warning Against Using Cholesterol-lowering Statins During Pregnancy
FDA: Medtronic Vascular Recalls Angiographic Guidewire Component Due to Being Non-sterile
FDA: Magellan Diagnostics Recalls LeadCare II, LeadCare Plus, and LeadCare Ultra Blood Lead Tests Due to Risk of Falsely Low Results
MedPage Today: Controversial Alzheimer's Drug Wins FDA Approval
FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014
FDA: Stop New Implants of the Medtronic HVAD System – Letter to Health Care Providers